This is directly demonstrated by our admix experiment where mice that received CCR2+ myeloid cells from WGP-trained mice showed a significantly reduced tumor burden as compared to mice that received CCR2- myeloid cells from the same trained mouse. This evidence concerns the gene CCR2 and neoplasm.